State of antioxidant, pro-oxidant and endothelial systems in patients with chronic critical lower limb ischemia and high risk of reperfusion-reoxygenation complications
Background. Obliterating atherosclerosis of the peripheral arterial vessels accounts for more than 20 % of cases of cardiovascular pathology, that is more than in 3 % of the total population. Despite the large experience of performing operative arterial interventions, the 3year ability of the femoral subcutaneous shunts does not exceed 80 %. The frequency of reocclusion of iliac arteries is from 6 to 42 %. The purpose of the research was to study the features of the oxidant, prooxidant and endothelial systems in patients with chronic critical lower limb ischemia. Materials and methods. The work is based on the analysis of complex examination and surgical treatment of 220 patients with obliterating atherosclerosis of aorta and main arteries of the lower extremities. The patients were divided into two groups in terms of volume of surgical revascularization of femoropopliteal arteries. In the first group of patients, operative intervention included onestage reconstruction of the aortafemoral and femoropopliteal segments, in patients of the second group, the reconstruction of the indicated segments was performed in two stages. The activity of the components of the prooxidantantioxidant system was determined using spectrophotometric methods. Results. Investigations of the activity of freeradical oxidation demonstrated that the processes involving the tissues of the lower limbs, due to the influence of oxygen free radicals on them, not only activate free radical processes, but can also enhance the processes of damaging effects on the tissue cells and, moreover, on the endothelial system. Conclusions. The risk of reperfusion complications in the postoperative period in patients is confirmed by the high level of the inflammatory response. When revascularization occurs, the destruction, detachment of endothelial cells, the spread of endothelial cellcell contacts contributes to increase of penetration of the endothelial layer.
Full Text:PDF (Українська)
Ryden L, Grant PJ, Anker SD, et al. ESC Guidelines on diabetes, prediabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J. 2013 Oct;34(39):3035-87. doi: 10.1093/eurheartj/eht108.
Schultz MJ, Dunser MW, Dondorp AM, et al. Current challenges in the management of sepsis in ICUs in resource-poor settings and suggestions for the future. Intensive Care Med. 2017 May;43(5):612-624. doi: 10.1007/s00134-017-4750-z.
Seymour CW, Liu VX, Iwashyna TJ, et al. Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016 Feb 23;315(8):762-74. doi: 10.1001/jama.2016.0288.
Shammas NW, Radaideh Q. A Combined Radial and Pedal Access to Treat a Flush Chronic Total Occlusion of the Superficial Femoral Artery in a Critical Limb Ischemia Patient. Open J Cardiovasc Surg. 2019 Mar 10;11:1179065219834523. doi: 10.1177/1179065219834523.
Sigvant B, Lundin F, Wahlberg E. The risk of disease progression in peripheral arterial disease is higher than expected: a meta-analysis of mortality and disease progression in peripheral arterial disease. Eur J Vasc Endovasc Surg. 2016 Mar;51(3):395-403. doi: 10.1016/j.ejvs.2015.10.022.
Aboyans V, Ricco JB, Bartelink MEL, et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J. 2018 Mar 1;39(9):763-816. doi: 10.1093/eurheartj/ehx095.
Strobl FF, Brechtel K, Schmehl J, et al. Twelve-month results of a randomized trial comparing mono with dual antiplatelet therapy in endovascularly treated patients with peripheral artery disease. J Endovasc Ther. 2013 Oct;20(5):699-706. doi: 10.1583/13-4275MR.1.
Sultan S, Chua BY, Hamada N, Hynes N. Preoperative vascular screening in the presence of aortic, carotid and peripheral pathology for patients undergoing their first arterial intervention: 18 month follow-up. Int Angiol. 2013 Jun;32(3):281-90.
European Stroke Organisation, Tendera M, Aboyans V, et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J. 2011 Nov;32(22):2851-906. doi: 10.1093/eurheartj/ehr211.
van de Weijer MA, Vonken EJ, de Vries JP, Moll FL, Vos JA, de Borst GJ. Technical and clinical success and long-term durability of endovascular treatment for atherosclerotic aortic arch branch origin obstruction: evaluation of 144 procedures. Eur J Vasc Endovasc Surg. 2015 Jul;50(1):13-20. doi: 10.1016/j.ejvs.2015.03.058.
Vemulapalli S, Dolor RJ, Hasselblad V, et al. Comparative effectiveness of medical therapy, supervised exercise, and revascularization for patients with intermittent claudication: a network meta-analysis. Clin Cardiol. 2015 Jun;38(6):378-86. doi: 10.1002/clc.22406.
Vincent JL, Marshall JC, Namendys-Silva SA, et al. Assessment of the worldwide burden of critical illness: the Intensive Care Over Nations (ICON) audit. Lancet Respir Med. 2014 May;2(5):380-6. doi: 10.1016/S2213-2600(14)70061-X.
This work is licensed under a Creative Commons Attribution 4.0 International License.
© "Publishing House "Zaslavsky", 1997-2019